Skip banner
HomeHow Do I?Site MapHelp
Return To Search FormFOCUS
Search Terms: needlestick, House or Senate or Joint

Document ListExpanded ListKWICFULL format currently displayed

Previous Document Document 2 of 19. Next Document

More Like This
Copyright 2000 Federal News Service, Inc.  
Federal News Service

June 22, 2000, Thursday

SECTION: PREPARED TESTIMONY

LENGTH: 2089 words

HEADLINE: PREPARED TESTIMONY OF KAREN DALEY, MPH, RN THE AMERICAN NURSES ASSOCIATION
 
BEFORE THE HOUSE EDUCATION AND THE WORKFORCE COMMITTEE SUBCOMMITTEE ON WORKFORCE PROTECTIONS

BODY:
 Good morning, Mr. Chairman and members of this distinguished subcommittee. I am Karen Daley, a registered nurse and president of the Massachusetts Nurses Association. I appear today on behalf ' of the American Nurses Association and its 53 constituent state and territorial nurses associations.

ANA appreciates having this opportunity to speak to you on an issue of great importance to the 2.6 million registered nurses and other health care workers in the United States who face the risk of potentially lethal needlesticks every day. For nearly twenty years, ANA has been calling for the use of safer devices and protections for health care workers.

Registered nurses have always cared for people in need whatever the circumstances, often with little regard to our own health and safety. Now we are in a situation in which health care workers sustain an estimated 600,000 needlestick injuries per year - at least 1,000 of those workers contract serious potentially life-threatening infections, like HIV and hepatitis C. And those numbers are probably too low - several studies show needlestick underreporting rates of between 40 and 90 percent. Despite the fact that these safer devices have been available since the 1970s and that we know more than 80% of needlestick injuries can be prevented through their use, fewer than 15 percent of U.S. hospitals have switched over to these safer devices, except in states that have enacted laws requiring them. As a result, thousands of health care workers each day are stuck by needles and needlessly exposed to disease. And for some truly unfortunate health care workers, one needlestick can become a devastating source of infection and illness that has a life-long, life-altering and life-threatening impact.

I am one of those cases. In July of 1998, while working in a hospital emergency department where I had been a nurse for more than 20 years, I sustained a needle stick. After a routine occupational health follow-up five months later - two days before Christmas - I received the horrifying news that I might be HIV and Hepatitis C positive. Just before New Year's of 1999, joined by a team of physicians, nurses and a social worker, I was told both infections had been confirmed. It's impossible for me to describe for you how that one moment - the moment when I reached my gloved hand into a needle box to dispose of the needle with which I had drawn blood - has drastically changed my life.

Up until this point in my life, I had enjoyed good health with little need to seek medical care beyond my annual visits to my primary care provider. Since that time. I have had to come to terms with the fact that I am infected with not one, but two potentially life-threatening diseases. As the direct result of my injury, for the first time in my life, I had become "a patient."

My primary care has been taken over by a physician who specializes in infectious diseases and particularly HIV management. I am also followed by a hepatologist who manages the hepatitis C. I have had weekly to monthly blood tests drawn - easily totaling hundreds of tubes over the past 18 months. In the early stages of my treatment, both of my doctors readily admitted that the experience and knowledge regarding the treatment of hepatitis C, in particular, was limited. The medical community's experience with treating both infections together was even more limited and problematic. What they do know based on their experience to date is that treating an individual infected with both HIV and hepatitis C can be much more difficult and that each infection can make it more complicated to successfully treat the other. Current research indicates that co-infection with HIV and hepatitis C can accelerate progression to liver failure. If treatment is not successful, it can mean that instead of the typical two or three decades before possible progression to liver cirrhosis or failure or cancer, a co-infected individual can progress in a much shorter time - as short a time as five to 10 years.

In the first year of my treatment, I took a daily regimen of potent antiviral drugs - a regimen that at one point consisted of 21 pills a day and an injection and caused a wide range of side effects, among them: weight loss, nausea, loss of appetite, hair loss, headaches, skin rashes, severe fatigue and bone marrow depression. To say these side effects interfered with my normal day-to-day routine is a gross understatement. The single moment when my injury occurred 18 months ago has changed many other things for me. In addition to the emotional turmoil it has created for myself, my family, my friends, my colleagues - it has cost me much more than I can ever describe in words. As a result of my injury, I have given up direct nursing practice, work that I love.

Mr. Chairman, this injury didn't occur because I wasn't observing universal precautions. I did everything within my power - taking all the necessary precautions including wearing gloves and following proper procedures - to reduce my own risk of exposure to bloodborne pathogens. This injury didn't occur because I was careless or distracted or not paying attention to what I was doing. This injury and the life-altering consequences I am now suffering should not have happened. And worst of all, this injury did not have to happen and would not have happened if a safer needle and disposal system had been in place in my own work setting.

We have made some progress. In November 1999, OSHA released a compliance directive to the Bloodborne Pathogens Standard. This directive provides instructions to OSHA inspectors to cite employers for failing to evaluate, purchase, and implement safer needles and sharps devices. While ANA commends OSHA for releasing this directive, we strongly believe this process should be taken one step further and that, for a number of reasons, these requirements need to be placed into the actual standard through federal legislation.

First, the legislation is needed for public sector employees who are not covered by OSHA. These and all health care workers must be protected through legislation. The reality is OSHA has no plans to enhance its enforcement programs or to increase the number of OSHA inspectors. At its current funding level, OSHA has the ability to make one spontaneous visit per facility about every 75 years. We also know that OSHA will increase the number of inspections in response to complaints. In the absence of complaints, however, workers are assuming unnecessary and potentially life-threatening risks in settings where safer devices are not being used. despite the directive and the widespread availability of these safer devices for more than 20 years.

We know the risk for health care workers and the cost to this nation will only grow over time since the present number of 4 million cases of hepatitis C alone is expected to triple over the next 20 years. As the current leading reason for liver failure and transplants, potential exposure and infection of health care workers with hepatitis C, the most common infection transmitted through needlesticks, represents not simply an occupational health and safety, issue, but a major public health issue. And hepatitis C is just one of more than 20 bloodborne pathogens we know can be transmitted through a needlestick.

As thousands of preventable needlestick injuries continue to occur around this country everyday, the cost of not requiring use of safer devices also grows. The average cost of follow-up for a high-risk exposure is almost $3,000 per needlestick injury even when no infection occurs.

Based on estimates of 600,000 needlesticks a year, the cost for follow-up alone is $1.8 billion. According to the American Hospital Association, once case of serious infection by bloodborne pathogens can soon add up to $1 million or more in expenditures for testing follow-up, lost time and disability payments. And while we know safer devices cost more, we also know they can prevent more than 80 percent of these injuries. And as these devices are used on a more widespread basis, we know their cost will approximate the amount currently spent on unsafe needle devices.

The federal legislation is needed to require involvement of frontline health care workers in the evaluation, selection, and implementation of safe devices. It is crucial that the selection and evaluation of safer devices not be left in the hands of those who may only understand how a device ought to work. Selection should be in the hands of those who are actually going to work with the device. It is also important to say that health care workers will often resist changing over to these newer safer systems. In reality, it is not unexpected that workers will go through some awkward years adapting to these new devices. That is not a good reason for failing to move forward since, with a consistent approach from within the industry and as these devices become the norm, we can expect that situation to change over time. Routinely involving the workers who use these devices in their selection has been shown to be one of the most effective ways to reduce their resistance to using them.

The legislation is also necessary for the collection of needlestick injury data to assess the device-specific injury rates in order to improve prevention programs and products. At present, the OSHA recordkeeping standard does not require reporting and recording of all needlestick injuries and provides no specific information about the device and working conditions surrounding the injury. We need that data to tell us which of the more than 1000 patented devices are the most effective. Simply because a device is labeled a safer device doesn't make it one and it isn't necessary for employers to buy the most expensive devices for an exposure control plan to be effective.

Finally, it is important to understand that compliance directives are easily subject to change and that amending the Bloodborne Pathogen Standard itself through regulation is too slow a process, given the unacceptable risks to which hundreds of nurses and other health care workers are exposed to every day. ANA urges Congress to amend the Standard by statute so that nurses and health care workers can be assured expeditious protection.In offering our strong support for federal legislation, I think it's also important to be clear on what we are and are not saying. We are not suggesting an unreasonable or cost-prohibitive approach to what we believe is a preventable and serious public health problem. We are not suggesting that employers use the most expensive devices on the market. We are saying that employers should choose and utilize devices that are found to be most effective in their own environment. We are saying that the financial resources should be used to prevent injuries and exposures, not simply to follow-up workers once they have needlessly been exposed. We are saying that the choice should no longer be between an employer saving relatively minuscule amounts of money on the front end while a worker pays with his health, piece of mind, and perhaps even his life.

Mr. Chairman, the American Nurses Association has been pleased in recent years to work with Representatives Stark and Roukema, who have led congressional efforts on this issue, and with our nursing colleagues who serve in the House of Representatives, including Representative Carolyn McCarthy, a distinguished member of this committee. We have worked also with a broad coalition of health care workers, institutional health care providers, and manufacturers to find a way to make sure that safer devices are the norm for every health care worker in America. ANA is committed to work with you and other members of this committee in this effort.

Institutions and health care professionals often speak of the importance of prevention. Hospitals and others that employ nurses and other health care workers have an obligation to apply the same standard of prevention for caregivers as they do for patients. We all must do everything possible to protect health care workers from unnecessary and preventable exposure to injury and disease. This legislation is critical to that end. I share my personal story with you today and I will continue to do this so no other nurse, doctor or other health care worker has to experience what I am going through.

Thank you for allowing me the opportunity to offer testimony on this important public health and workplace issue.

END

LOAD-DATE: June 23, 2000




Previous Document Document 2 of 19. Next Document


FOCUS

Search Terms: needlestick, House or Senate or Joint
To narrow your search, please enter a word or phrase:
   
About LEXIS-NEXIS® Congressional Universe Terms and Conditions Top of Page
Copyright © 2002, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.